Protagenic Therapeutics (PTIXW) Competitors

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

$0.03

0.00 (0.00%)

(As of 04/19/2024 ET)

Stock Analysis Chart Competitors Financials SEC Filings Social Media

PTIXW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Protagenic Therapeutics stock or one of its competitors? The main competitors of Protagenic Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Protagenic Therapeutics vs.

180 Life Sciences (NASDAQ:ATNFW) and Protagenic Therapeutics (NASDAQ:PTIXW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

: 180 Life Sciences and Protagenic Therapeutics both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
180 Life Sciences N/A N/A
Protagenic Therapeutics N/A N/A
: Company Net Margins Return on Equity Return on Assets
180 Life Sciences N/A N/A N/A
Protagenic Therapeutics N/A N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Protagenic Therapeutics
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: In the previous week, Protagenic Therapeutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
Company Overall Sentiment
180 Life Sciences Neutral
Protagenic Therapeutics Neutral
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
180 Life Sciences N/A N/A N/A N/A N/A
Protagenic Therapeutics N/A N/A N/A N/A N/A

Company	Underperform	Outperform
180 Life Sciences	N/A	N/A
Protagenic Therapeutics	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
180 Life Sciences	N/A	N/A	N/A
Protagenic Therapeutics	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Protagenic Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Overall Sentiment
180 Life Sciences	Neutral
Protagenic Therapeutics	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
180 Life Sciences	N/A	N/A	N/A	N/A	N/A
Protagenic Therapeutics	N/A	N/A	N/A	N/A	N/A

Summary

180 Life Sciences and Protagenic Therapeutics tied by winning 0 of the 0 factors compared between the two stocks.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Get Protagenic Therapeutics News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTIXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PTIXW vs. The Competition

Export to Excel

Metric	Protagenic Therapeutics	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$170.50M	$4.80B	$7.30B
Dividend Yield	N/A	3.48%	2.94%	4.01%
P/E Ratio	N/A	213.54	269.16	20.04
Price / Sales	N/A	12,805.87	2,456.86	89.18
Price / Cash	N/A	11.28	47.10	34.82
Price / Book	N/A	5.12	4.55	4.16
Net Income	N/A	-$18.84M	$104.05M	$214.20M
7 Day Performance	N/A	-2.61%	-4.50%	-3.54%
1 Month Performance	N/A	-5.06%	-6.08%	-4.09%
1 Year Performance	N/A	51.21%	6.70%	3.28%

Protagenic Therapeutics Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars	$0.01 flat	N/A	-47.9%	$0.00	N/A	4	Gap Up
SXTPW 60 Degrees Pharmaceuticals	0 of 5 stars	$0.11 flat	N/A	N/A	$0.00	$90,718.00	2	Positive News
DRTSW Alpha Tau Medical	0 of 5 stars	$0.26 +4.0%	N/A	+6.8%	$0.00	N/A	121	News Coverage Gap Up
APLMW Apollomics	0 of 5 stars	$0.03 flat	N/A	-77.8%	$0.00	N/A	59
ARTLW Artelo Biosciences	0 of 5 stars	$0.02 flat	N/A	N/A	$0.00	N/A	5	Positive News
BCDAW BioCardia	0 of 5 stars	$0.03 +50.5%	N/A	-98.0%	$0.00	$477,000.00	30	Gap Up
BCTXW BriaCell Therapeutics	0 of 5 stars	$1.08 -12.9%	N/A	-67.0%	$0.00	N/A	16	Gap Down High Trading Volume
CDIOW Cardio Diagnostics	0 of 5 stars	$0.08 +14.3%	N/A	-74.8%	$0.00	$17,065.00	7	Gap Up
CTCXW Carmell	0 of 5 stars	$0.15 flat	N/A	N/A	$0.00	$3.73M	9	Positive News Gap Up
SAVAW Cassava Sciences	0 of 5 stars	$6.17 +38.6%	N/A	N/A	$0.00	N/A	29	Gap Up

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:PTIXW) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Protagenic Therapeutics (PTIXW) Competitors

PTIXW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Protagenic Therapeutics vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PTIXW vs. The Competition

Protagenic Therapeutics Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info